{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:15:45Z","timestamp":1785392145813,"version":"3.55.0"},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1248\/bpb.b18-00444","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T22:40:07Z","timestamp":1541025607000},"page":"1694-1700","source":"Crossref","is-referenced-by-count":23,"title":["Risk Factors for Eye Disorders Caused by Paclitaxel: A Retrospective Study"],"prefix":"10.1248","volume":"41","author":[{"given":"Yusuke","family":"Noguchi","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Kawara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tokuyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kyoto Okamoto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Kashiwagi H. Ocular disorders of anticancer drugs\u2014ocular side effects. <i>Gan To Kagaku Ryoho<\/i>, <b>37<\/b>, 1639\u20131644 (2010)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mansur C, Pfeiffer ML, Esmaeli B. Evaluation and management of chemotherapy-induced epiphora, punctal and canalicular stenosis, and nasolacrimal duct obstruction. <i>Ophthal. Plast. Reconstr. Surg.<\/i>, <b>33<\/b>, 9\u201312 (2017).","DOI":"10.1097\/IOP.0000000000000745"},{"key":"3","unstructured":"3) Noguchi Y, Kawahara Y, Omori K, Matsumoto K, Minegaki T, Tsujimoto M, Nishiguchi K, Tokuyama Y. Introduction and evaluation of all adverse effect reporting service provided by pharmacists stationed in the outpatient cancer chemotherapy room. <i>J. Jpn. Soc. Hosp. Pharm.<\/i>, <b>46<\/b>, 1273\u20131277 (2010)."},{"key":"4","unstructured":"4) Noguchi Y, Nishimura R, Kawara H, Omori K, Matsumoto K, Tokuyama Y, Uchiyama K, Shimizu Y. Survey of current status of adverse ocular reactions to paclitaxel and a retrospective analysis for aiding in early detection of adverse reactions. <i>Gan To Kagaku Ryoho<\/i>, <b>40<\/b>, 819\u2013822 (2013)."},{"key":"5","unstructured":"5) Noguchi Y, Mitani T, Kawara H, Tokuyama Y, Tamura Y, Uchiyama K, Shimizu Y. A case of lacrimal duct obstruction caused by capecitabine. <i>Gan To Kagaku Ryoho<\/i>, <b>42<\/b>, 123\u2013125 (2015)."},{"key":"6","unstructured":"6) Noguchi Y, Kawashima Y, Kawara H, Tokuyama Y, Tamura Y, Uchiyama K, Shimizu Y. A retrospective analysis of eye disorders due to oxaliplatin. <i>Gan To Kagaku Ryoho<\/i>, <b>42<\/b>, 1401\u20131405 (2015)."},{"key":"7","unstructured":"7) Noguchi Y, Kawashima Y, Kawara H, Tokuyama Y, Tamura Y, Uchiyama K, Shimizu Y. A retrospective analysis of epiphora due to docetaxel. <i>Gan To Kagaku Ryoho<\/i>, <b>43<\/b>, 737\u2013741 (2016)."},{"key":"8","unstructured":"8) Noguchi Y, Kawashima Y, Kawara H, Kaneko M, Nakauchi H, Tokuyama Y. An undeniable case of optic neuropathy due to cabazitaxel. <i>Gan To Kagaku Ryoho<\/i>, <b>43<\/b>, 777\u2013779 (2016)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Capri G, Munzone E, Tarenzi E, Fulfaro F, Gianni L, Caraceni A, Martini C, Scaioli V. Optic nerve disturbances: a new form of paclitaxel neurotoxicity. <i>J. Natl. Cancer Inst.<\/i>, <b>86<\/b>, 1099\u20131101 (1994).","DOI":"10.1093\/jnci\/86.14.1099"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Seidman AD, Barrett S, Canezo S. Photopsia during 3-hour paclitaxel administration at doses \u2265250\u2009mg\/m<sup>2<\/sup>. <i>J. Clin. Oncol.<\/i>, <b>12<\/b>, 1741\u20131742 (1994).","DOI":"10.1200\/JCO.1994.12.8.1741"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hofstra LS, de Vries EG, Willemse PH. Ophthalmic toxicity following paclitaxel infusion. <i>Ann. Oncol.<\/i>, <b>8<\/b>, 1053 (1997).","DOI":"10.1023\/A:1008249230056"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Scaioli V, Caraceni A, Martini C, Curzi S, Capri G, Luca G. Electrophysiological evaluation of visual pathways in paclitaxel-treated patients. <i>J. Neurooncol.<\/i>, <b>77<\/b>, 79\u201387 (2006).","DOI":"10.1007\/s11060-005-9008-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) McCartney E, Valluri S, Rushing D, Burgett R. Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel. <i>Ophthal. Plast. Reconstr. Surg.<\/i>, <b>23<\/b>, 170\u2013171 (2007).","DOI":"10.1097\/IOP.0b013e318032e908"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Joshi MM, Garretson BR. Paclitaxel maculopathy. <i>Arch. Ophthalmol.<\/i>, <b>125<\/b>, 709\u2013710 (2007).","DOI":"10.1001\/archopht.125.5.709"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Smith SV, Benz MS, Brown DM. Cystoid macular edema secondary to albumin-bound paclitaxel therapy. <i>Arch. Ophthalmol.<\/i>, <b>126<\/b>, 1605\u20131606 (2008).","DOI":"10.1001\/archopht.126.11.1605"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kuznetcova TI, Cech P, Herbort CP. The mystery of angiographically silent macular oedema due to taxanes. <i>Int. Ophthalmol.<\/i>, <b>32<\/b>, 299\u2013304 (2012).","DOI":"10.1007\/s10792-012-9558-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Lee HS, Ha JY, Choi W, Yoon KC. Bilateral corneal epithelial lesions associated with paclitaxel. <i>Optom. Vis. Sci.<\/i>, <b>93<\/b>, 1333\u20131336 (2016).","DOI":"10.1097\/OPX.0000000000000945"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Georgakopoulos CD, Makri OE, Vasilakis P, Exarchou A. Angiographically silent cystoid macular oedema secondary to paclitaxel therapy. <i>Clin. Exp. Optom.<\/i>, <b>95<\/b>, 233\u2013236 (2012).","DOI":"10.1111\/j.1444-0938.2011.00672.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ham DS, Lee JE, Kim HW, Yun IH. A case of cystoid macular edema associated with paclitaxel chemotherapy. <i>Korean J. Ophthalmol.<\/i>, <b>26<\/b>, 388\u2013390 (2012).","DOI":"10.3341\/kjo.2012.26.5.388"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Koo NK, Kim YC. A case of paclitaxel-induced maculopathy treated with methazolamide. <i>Korean J. Ophthalmol.<\/i>, <b>26<\/b>, 394\u2013397 (2012).","DOI":"10.3341\/kjo.2012.26.5.394"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Modi D, Dubovy SR. Non-leaking cystoid maculopathy secondary to systemic paclitaxel. <i>Ophthalmic Surg. Lasers Imaging Retina<\/i>, <b>44<\/b>, 183\u2013186 (2013).","DOI":"10.3928\/23258160-20130218-01"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Freitas-da-Costa P, Brand\u00e3o E, Bragan\u00e7a T, Falc\u00e3o-Reis F, Carneiro A. Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction. <i>Cutan. Ocul. Toxicol.<\/i>, <b>34<\/b>, 347\u2013349 (2015).","DOI":"10.3109\/15569527.2014.996294"},{"key":"23","unstructured":"23) Tezcan Y, Surmeli M, Tastekin D, Koc M. Bilateral cystoid macular edema secondary to paclitaxel treatment. <i>Arch. Iran Med.<\/i>, <b>18<\/b>, 606\u2013607 (2015)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nakao S, Ikeda Y, Emi Y, Ishibashi T. Possibility of M\u00fcller cell dysfunction as the pathogenesis of paclitaxel maculopathy. <i>Ophthalmic Surg. Lasers Imaging Retina<\/i>, <b>47<\/b>, 81\u201384 (2016).","DOI":"10.3928\/23258160-20151214-14"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Dwivedi R, Tiroumal S. Possible efficacy of topical dorzolamide in the treatment of paclitaxel-related cystoid macular edema. <i>Retin. Cases Brief Rep.<\/i>, <b>12<\/b>, 75\u201379 (2018).","DOI":"10.1097\/ICB.0000000000000433"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Murphy CG, Walsh JB, Hudis CA, Lake D, Theodoulou M. Cystoid macular edema secondary to nab-paclitaxel therapy. <i>J. Clin. Oncol.<\/i>, <b>28<\/b>, e684\u2013e687 (2010).","DOI":"10.1200\/JCO.2010.30.3750"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Rahimy E, Sarraf D. Cystoid macular edema secondary to nanoparticle albumin-bound paclitaxel therapy. <i>Ophthalmic Surg. Lasers Imaging Retina<\/i>, <b>44<\/b>, 187\u2013189 (2013).","DOI":"10.3928\/23258160-20130212-02"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Rahman HT, Yeh S, Bergstrom CS. Cystoid macular edema without leakage secondary to nab-paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab. <i>J. Ocul. Pharmacol. Ther.<\/i>, <b>29<\/b>, 360\u2013362 (2013).","DOI":"10.1089\/jop.2011.0178"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Matsuoka N, Hasebe H, Mayama T, Fukuchi T. Sub-tenon injections of triamcinolone acetonide had limited effect on cystoid macular edema secondary to nanoparticle albumin-bound-paclitaxel (Abraxane). <i>Case Rep. Ophthalmol. Med.<\/i>, <b>2015<\/b>, 181269 (2015).","DOI":"10.1155\/2015\/181269"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Tanaka Y, Bando H, Hara H, Ito Y, Okamoto Y. Cystoid macular edema induced by nab-paclitaxel. <i>Breast Cancer<\/i>, <b>22<\/b>, 324\u2013326 (2015).","DOI":"10.1007\/s12282-012-0373-y"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Hassall MM, Andrew NH. Single-eye trial of a topical carbonic anhydrase inhibitor <i>versus<\/i> intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema. <i>BMJ Case Rep.<\/i>, doi: 10.1136\/bcr-2015-212733 (2016).","DOI":"10.1136\/bcr-2015-212733"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Park E, Goldberg NR, Adams S. Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy. <i>Anticancer Drugs<\/i>, <b>27<\/b>, 580\u2013584 (2016).","DOI":"10.1097\/CAD.0000000000000361"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, <b>48<\/b>, 452\u2013458 (2013).","DOI":"10.1038\/bmt.2012.244"},{"key":"34","unstructured":"34) TAXOL Japanese interview form."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Esmaeli B, Ahmadi MA, Rivera E, Valero V, Hutto T, Jackson DM, Newman RA. Docetaxel secretion in tears: association with lacrimal drainage obstruction. <i>Arch. Ophthalmol.<\/i>, <b>120<\/b>, 1180\u20131182 (2002).","DOI":"10.1001\/archopht.120.9.1180"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Esmaeli B, Hortobagyi GN, Esteva FJ, Booser D, Ahmadi MA, Rivera E, Arbuckle R, Delpassand E, Guerra L, Valero V. Canalicular stenosis secondary to weekly <i>versus<\/i> every-3-weeks docetaxel in patients with metastatic breast cancer. <i>Ophthalmology<\/i>, <b>109<\/b>, 1188\u20131191 (2002).","DOI":"10.1016\/S0161-6420(02)00989-2"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/11\/41_b18-00444\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T04:35:56Z","timestamp":1541219756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/11\/41_b18-00444\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00444","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}